Lisa Lancaster, MD, is an expert interstitial lung disease (ILD) clinician with more than 20 years of experience in clinical trials.
She joined the faculty of the Vanderbilt following fellowship and began as the ILD Program Director in 2000. Since then, the Vanderbilt IPF and ILD Research Program has completed over 80 clinical trials and registries. Dr. Lancaster has served on multiple ILD steering committees and advisory boards and has authored or coauthored over 80 publications in ILD.
She has been an invited speaker for national and international webinars and lectures. Her national leadership roles have included membership in the Steering Committee for the Diffuse Lung Disease Network of the American College of Chest Physicians and the Steering Committee for the Pulmonary Fibrosis Foundation Registry. Recently, her research interests have expanded to include device development in oxygen delivery systems, which led to an NIH and HeroX Challenge first place award and an NIH C3i business development training grant.
Dr. Lancaster attends clinically in ILD clinic, sleep clinic, and on the Rogers Pulmonary general pulmonary service.